AccuStem Sciences to Present at the Life Sciences Virtual Investor Forum September 18th

Group 1 - AccuStem Sciences, Inc. will present at the Life Sciences Virtual Investor Forum on September 18, 2025, with CEO Wendy Blosser leading the presentation [1][2] - The event will allow real-time interaction between investors and the company, with archived webcasts available for those unable to attend live [2][3] - AccuStem focuses on proprietary molecular testing to improve cancer patient outcomes and address unmet clinical needs [4] Group 2 - The Virtual Investor Conferences platform provides an interactive forum for publicly traded companies to connect directly with investors [6][7] - VIC enhances investor engagement by offering features such as targeted one-on-one meetings and dynamic video content [7]